Open AccessAssessment of dabigatran plasma concentration may improve the safety of anticoagulation in patients treated with ibrutinib with concomitant atrial fibrillation
Author(s) -
Ewa Lewicka,
Paulina Daniluk,
Zofia Lasocka,
Ewa Zarzycka,
Alicja Dąbrowska-Kugacka,
Izabela Nabiałek-Trojanowska,
Jan Maciej Zaucha
Publication year - 2020
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.15255
Subject(s) - medicine , dabigatran , atrial fibrillation , concomitant , ibrutinib , idarucizumab , cardiology , plasma concentration , warfarin , chronic lymphocytic leukemia , leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom